References
- Takasugi M, Terasaki P I, Henderson B, Mickey M R, Menck H, Thompson RW. HLA-A antigens in solid tumors. Cancer Res 1973; 33: 648–50
- Tarpley J L, Chretien P B, Rogentine GN., Jr., Twomey P L, Dellon AL. Histocompatibility antigens and solid malignant neoplasms. Arch Surg 1975; 110: 269–71
- Dellon A L, Rogentine GN., Jr., Chretien PB. Prolonged survival in bronchogenic carcinoma associated with HLA antigens W-19 and HLA-A5. A preliminary report. J Natl Cancer Inst 1975; 54: 1283–6
- Rogentine GN, Jr., Dellon A L, Chretien PB. Prolonged disease-free survival in brochogenic carcinoma associated with HLA-AW19 and HLA-B5. Cancer 1977; 39: 2345–7
- Sengar D PS, McIeish W A, Stewart T HM, Harris JE. HLA antigens in bronchogenic carcinoma. Oncology 1977; 34: 143–5
- Weiss G B, Nawrocki L B, Daniels JC. HLA type and survival in lung cancer. Cancer 1980; 46: 38–40
- Ford C HJ, Newman C E, Mackintosh P. HLA frequency and prognosis in lung cancer. Br J Cancer 1981; 43: 610–4
- Tongio M M, Kerschen C, Pauli G, Roeslin N, Grange D, Mayer S. HLA antigens and primary bronchial carcinoma. Cancer 1982; 49: 2485–8
- Markman M, Braine H G, Abeloff MD. Histocompatibility antigens in small cell carcinoma of the lung. Cancer 1984; 54: 2943–5
- Lam W K, Hawkins B R, Kung I TM, So SY. No association between HLA antigens and adenocarcinoma of the lung in non-smoking Chinese women in Hong Kong. Br J Dis Chest 1986; 80: 370–4
- Mericka O, Zatloukal P, Prazak J. Main histocompatibility system in bronchogenic carcinoma. Sb Lek 1988; 90: 314–7
- Prazak J, Mericka O. HLA and bronchogenic carcinoma. Neoplasma 1989; 36: 599–602
- Dausset J. HLA and association with malignancy. A critical view. HLA and malignancy. New York, NY 1977; 131–4
- Simons M J, Wee G B, Day N E, Morris P J, Schanmugaratnam K, de The GB. Immunogenetics aspects of nasopharyngeal carcinoma. I. Difference in HLA antigen profiles between patients and control groups. Int J Cancer 1974; 13: 122–34
- Simons M J, Amiel JL. HLA and disease. Munksgaard, Copenhagen 1977; 221–2
- NIH: NIH lymphocyte microtoxicity technique. NIAID manual of tissue typing techniques. 1976; 22–4
- Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251–3
- Haldane J BS. The estimation and significance of logarithm of a ratio of frequencies. Ann Hum Genet 1955; 20: 309–11
- Doyle A, Martin W J, Funa K, et al. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med 1985; 161: 1135–51